Recent Finacing
Recent Raise
Cocrystal Discovery develops oral small-molecule inhibitors of viral replication enzymes (HCV, influenza, rhinovirus) using high-resolution X-ray crystallography and computational structure-based design from labs in Bothell and Mountain View.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor